News
Tirzepatide may confer larger increases in testosterone levels among men with metabolic hypogonadism than testosterone ...
Men receiving tirzepatide showed greater reductions in body weight and waist circumference and improvements in erectile ...
On its clinic website, the supermarket chain said the self-injectable pens can be used once a week to increase a user’s chance of sustained weight loss, amounted to around 20% of their bodyweight in a ...
A new study reports that GLP-1 medications may improve low testosterone in men with obesity or type 2 diabetes. The findings ...
Postmenopausal women struggling with weight loss may find a powerful solution by combining the diabetes drug tirzepatide with menopause hormone therapy. A Mayo Clinic study revealed that this dual ...
The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced obesity-associated breast cancer growth in a mouse model, according to a study being ...
The primary outcome assessed was a diagnosis of erectile dysfunction or the initiation of phosphodiesterase type 5 (PDE-5) inhibitor therapy, which is commonly used to treat ED. The study yielded the ...
Sex experts and medical doctors weigh in on the different types of erectile dysfunction, how to identify them, and solutions for erectile dysfunction.
Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions in body weight and waist circumference.
LGBTQ dating app Grindr is introducing Woodwork, a telehealth service that offers access to erectile dysfunction meds.
It contains tirzepatide, which is the active ingredient in the brand-name drug Mounjaro. If you cannot take Mounjaro for medical reasons, you may need compounded tirzepatide.
Researchers at the Pennington Biomedical Research Center conducted a first-of-its-kind study to provide insights into the mechanisms of action of tirzepatide—a drug known as Zepbound—on weight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results